(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
1.65% $ 262.40
@ $261.16
Emitido: 3 may 2024 @ 09:31
Retorno: 0.47%
Señal anterior: may 1 - 13:54
Señal anterior:
Retorno: 3.96 %
Live Chart Being Loaded With Signals
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally...
Stats | |
---|---|
Volumen de hoy | 540 354 |
Volumen promedio | 507 708 |
Capitalización de mercado | 11.64B |
EPS | $0 ( 2024-05-01 ) |
Próxima fecha de ganancias | ( $5.65 ) 2024-06-25 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 12.42 |
ATR14 | $6.25 (2.38%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Rothblatt Martine A | Sell | 3 600 | Stock Options |
2024-05-02 | Rothblatt Martine A | Sell | 3 600 | Stock Options |
2024-05-02 | Rothblatt Martine A | Buy | 3 600 | Common Stock |
2024-05-02 | Rothblatt Martine A | Sell | 191 | Common Stock |
2024-05-01 | Rothblatt Martine A | Sell | 238 | Common Stock |
INSIDER POWER |
---|
-56.66 |
Last 100 transactions |
Buy: 31 200 | Sell: 112 800 |
Volumen Correlación
United Therapeutics Corp Correlación
10 Correlaciones Más Positivas | |
---|---|
BOCH | 0.917 |
EMBCV | 0.911 |
PUI | 0.882 |
ISRG | 0.874 |
SHSP | 0.864 |
MMAC | 0.852 |
HALO | 0.85 |
HOUR | 0.838 |
IBCP | 0.837 |
IMKTA | 0.837 |
10 Correlaciones Más Negativas | |
---|---|
GAINL | -0.934 |
APOP | -0.93 |
TDAC | -0.928 |
RMRM | -0.876 |
ISNS | -0.861 |
CMLF | -0.852 |
INZY | -0.826 |
NTEC | -0.819 |
MAGS | -0.814 |
SVOK | -0.813 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
United Therapeutics Corp Correlación - Moneda/Commodity
United Therapeutics Corp Finanzas
Annual | 2023 |
Ingresos: | $2.33B |
Beneficio Bruto: | $2.07B (88.94 %) |
EPS: | $21.04 |
FY | 2023 |
Ingresos: | $2.33B |
Beneficio Bruto: | $2.07B (88.94 %) |
EPS: | $21.04 |
FY | 2022 |
Ingresos: | $1.94B |
Beneficio Bruto: | $1.79B (92.42 %) |
EPS: | $15.98 |
FY | 2021 |
Ingresos: | $1.69B |
Beneficio Bruto: | $1.56B (92.73 %) |
EPS: | $10.60 |
Financial Reports:
No articles found.
United Therapeutics Corp
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin analogue treprostinil to enhance the exercise ability in PAH patients and pulmonary hypertension associated with interstitial lung disease (PH-ILD); Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing Tyvaso DPI, a dry powder inhalation form of Tyvaso; Remunity Pump, a small, lightweight, durable pump and separate controller; RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and Tyvaso PERFECT and TETON studies, which are the studies of Tyvaso in patients with World Health Organization (WHO) Group 3 pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico